AI-Designed Antibodies: Scientifically Sound, Commercially Doubtful
anshulkundaje · x · 2026-07-17
A long article on AI-designed antibodies, the author's core judgment:
- Scientifically, this direction is solid, not just another round of pure hype
- But commercially, whether it can become a good business remains questionable
The post relays a measured conclusion: he has experienced many similar "revolutionary" narratives; this time it's more like genuine scientific progress, but the commercialization path may not be equally smooth.
More from Companies & People
- Anthropic's S-1 Shows $6.6M Revenue Per Employee as AI Agents Log 6x Human Hours — jacalulu · 2026-10-26
- Anthropic report: AI agents now log 6x employee hours, $6.6M revenue per head — jacalulu · 2026-10-26
- testingcatalog shares Berlin event slide teasing wave of releases including ChatGPT Space — testingcatalog · 2026-10-26
- Anthropic's IPO filing devotes 94 pages to existential AI risks, from self-preservation to blackmail — Polymarket · 2026-10-26
- Anthropic S-1: expert-level AI 'within a few years', 90% of code written by Claude — kimmonismus · 2026-10-26
- Anthropic files S-1: IPO expected between Nov 2026 and Feb 2027, valuation up 15x — alliekmiller · 2026-10-26